Handling and Exposure

Because gene therapies may utilize viral vectors, they are to be considered biohazardous materials and must be handled using proper procedures. We asked pharmacy professionals with experience in introducing gene therapy into their institutions to provide their insights into the key considerations for the safe handling of gene therapies

The experts touched on topics such as the properties of gene therapies that can inform handling practices, required personal protective equipment, the safe storage and transport of gene therapies, best practices for the preparation of gene therapies, decontamination and disposal of waste products, and how to address accidental exposure


Explore these other topics for preparing your institution for gene therapy: